Universe Pharmaceuticals (Universe Pharmaceuticals) EV-to-Revenue : -0.13 (As of May. 27, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Universe Pharmaceuticals EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Universe Pharmaceuticals's enterprise value is $-4.27 Mil. Universe Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $32.31 Mil. Therefore, Universe Pharmaceuticals's EV-to-Revenue for today is -0.13.

The historical rank and industry rank for Universe Pharmaceuticals's EV-to-Revenue or its related term are showing as below:

UPC' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.32 Med: 0.02 Max: 3.35
Current: -0.13

During the past 6 years, the highest EV-to-Revenue of Universe Pharmaceuticals was 3.35. The lowest was -0.32. And the median was 0.02.

UPC's EV-to-Revenue is ranked better than
98.83% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 2.29 vs UPC: -0.13

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), Universe Pharmaceuticals's stock price is $2.40. Universe Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $8.91. Therefore, Universe Pharmaceuticals's PS Ratio for today is 0.27.

Universe Pharmaceuticals EV-to-Revenue Historical Data

The historical data trend for Universe Pharmaceuticals's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universe Pharmaceuticals EV-to-Revenue Chart

Universe Pharmaceuticals Annual Data

Trend

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

EV-to-Revenue

Get a 7-Day Free Trial

0.76

-0.07

-0.30

Universe Pharmaceuticals Semi-Annual Data
	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EV-to-Revenue	Get a 7-Day Free Trial						0.76	-	-0.07	-	-0.30

Competitive Comparison of Universe Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Universe Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Universe Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Universe Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Universe Pharmaceuticals's EV-to-Revenue falls into.

Universe Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Universe Pharmaceuticals's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	-4.271	/	32.309
	=	-0.13

Universe Pharmaceuticals's current Enterprise Value is $-4.27 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Universe Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $32.31 Mil.

Universe Pharmaceuticals (NAS:UPC) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Universe Pharmaceuticals's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	2.40	/	8.912
	=	0.27

Universe Pharmaceuticals's share price for today is $2.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Sep. 2023 was $8.91.

Universe Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Universe Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Universe Pharmaceuticals (Universe Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Universe Pharmaceuticals Inc (NAS:UPC) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

265 Jingjiu Avenue, Economic & Technological Development Zone, Jinggangshan, Jiangxi, Ji’an, CHN

Website

http://www.universe-pharmacy.com

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.